PMEPA1 and hepatocellular carcinoma: Yuan et al. identified down-regulation of SKI like proto-oncogene (SKIL) and prostate transmembrane androgen-induced 1 protein (PMEPA1) after LY treatment as biomarkers for response in hepatocellular carcinoma (HCC) patients [52].